Ioxaglic acid

Jump to navigation Jump to search

{{Drugbox | IUPAC_name = 3-[(2-hydroxyethyl)carbamoyl]-2,4,6-triiodo-5-(2-{[2,4,6-triiodo-3-(methylcarbamoyl)-5-(N-methylacetamido)phenyl]formamido}acetamido)benzoic acid | image = Ioxaglic acid wiki str.png


| tradename = | Drugs.com = International Drug Names | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration =

| bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion =

| CAS_number = | ATC_prefix = V08 | ATC_suffix = AB03 | PubChem = 3742 | DrugBank = | UNII_Ref =  ☑Y | UNII = Z40X7EI2AF | KEGG = D01761 | ChEMBL = 1201291 | ChemSpiderID = 3611

| chemical_formula = | C=24 | H=21 | I=6 | N=5 | O=8 | molecular_weight = 1268.87906 g/mol | smiles = CC(=O)N(C)C1=C(C(=C(C(=C1I)C(=O)NCC(=O)NC2=C(C(=C(C(=C2I)C(=O)O)I)C(=O)NCCO)I)I)C(=O)NC)I | InChI = 1/C24H21I6N5O8/c1-7(37)35(3)20-17(29)10(21(39)31-2)13(25)11(18(20)30)23(41)33-6-8(38)34-19-15(27)9(22(40)32-4-5-36)14(26)12(16(19)28)24(42)43/h36H,4-6H2,1-3H3,(H,31,39)(H,32,40)(H,33,41)(H,34,38)(H,42,43) | InChIKey = TYYBFXNZMFNZJT-UHFFFAOYAE | StdInChI = 1S/C24H21I6N5O8/c1-7(37)35(3)20-17(29)10(21(39)31-2)13(25)11(18(20)30)23(41)33-6-8(38)34-19-15(27)9(22(40)32-4-5-36)14(26)12(16(19)28)24(42)43/h36H,4-6H2,1-3H3,(H,31,39)(H,32,40)(H,33,41)(H,34,38)(H,42,43) | StdInChIKey = TYYBFXNZMFNZJT-UHFFFAOYSA-N

}}

WikiDoc Resources for Ioxaglic acid

Articles

Most recent articles on Ioxaglic acid

Most cited articles on Ioxaglic acid

Review articles on Ioxaglic acid

Articles on Ioxaglic acid in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Ioxaglic acid

Images of Ioxaglic acid

Photos of Ioxaglic acid

Podcasts & MP3s on Ioxaglic acid

Videos on Ioxaglic acid

Evidence Based Medicine

Cochrane Collaboration on Ioxaglic acid

Bandolier on Ioxaglic acid

TRIP on Ioxaglic acid

Clinical Trials

Ongoing Trials on Ioxaglic acid at Clinical Trials.gov

Trial results on Ioxaglic acid

Clinical Trials on Ioxaglic acid at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Ioxaglic acid

NICE Guidance on Ioxaglic acid

NHS PRODIGY Guidance

FDA on Ioxaglic acid

CDC on Ioxaglic acid

Books

Books on Ioxaglic acid

News

Ioxaglic acid in the news

Be alerted to news on Ioxaglic acid

News trends on Ioxaglic acid

Commentary

Blogs on Ioxaglic acid

Definitions

Definitions of Ioxaglic acid

Patient Resources / Community

Patient resources on Ioxaglic acid

Discussion groups on Ioxaglic acid

Patient Handouts on Ioxaglic acid

Directions to Hospitals Treating Ioxaglic acid

Risk calculators and risk factors for Ioxaglic acid

Healthcare Provider Resources

Symptoms of Ioxaglic acid

Causes & Risk Factors for Ioxaglic acid

Diagnostic studies for Ioxaglic acid

Treatment of Ioxaglic acid

Continuing Medical Education (CME)

CME Programs on Ioxaglic acid

International

Ioxaglic acid en Espanol

Ioxaglic acid en Francais

Business

Ioxaglic acid in the Marketplace

Patents on Ioxaglic acid

Experimental / Informatics

List of terms related to Ioxaglic acid

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Ioxaglic acid (trade name Hexabrix) is an iodine containing molecule used as a low-osmolality contrast medium.[1]

References

  1. PMID 6999377 (PMID 6999377)
    Citation will be completed automatically in a few minutes. Jump the queue or expand by hand

Template:Contrast media


Template:Pharmacology-stub